Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease(2024)10.1016/j.bbadis.2024.167572Source: DataRank Database

Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis is a research paper published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

geo gen refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: hybridTopics (16)IDs (PubMed, PMC)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Asres Berhan ORCID,Eun Kyu Sung,Juan R. Alvarez,Hongjun Wang ORCID,Yanbin Ji

Live enrichment

PubMed:39547519 PMC:PMC11951472

Cystic Fibrosis Foundation Therapeutics

Grant: FIRTH21XX0

National Heart Lung and Blood Institute

Grant: R01HL114959

National Heart Lung and Blood Institute

Grant: R35 HL135747

Tobacco-Related Disease Research Program

Grant: T31IP913

NCI NIH HHS

Grant: P30 CA014089

Pulmonary Fibrosis Foundation

National Institutes of Health National Cancer Institute

Cystic Fibrosis Foundation

National Institutes of Health

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.bbadis.2024.167572

publisherhttps://api.elsevier.com/content/article/PII:S0925443924005660?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0925443924005660?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11951472/pdf/nihms-2062736.pdf

Europe_PMChttps://europepmc.org/articles/PMC11951472

MeSH Terms

AnimalsHumansMiceCell Cycle ProteinsEpigenesis, GeneticIdiopathic Pulmonary FibrosisEpithelial-Mesenchymal TransitionTranscriptomeAlveolar Epithelial CellsATPases Associated with Diverse Cellular Activities

Keywords

Rna-seqIdiopathic Pulmonary Fibrosis (Ipf)Trip13Atac-seqEpithelial-mesenchymal PlasticityEpigenomic Analysis

Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis

FAIR Checklist

Authors (19)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)